Constellation Software Inc. Announces Annual Interest Rate for Series 1 Debentures
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU, TSX: CSU.DB) (the "Company") announced today that the interest rate applicable to the unsecured subordinated floating rate debentures, Series 1 of the Company (the "Debentures") will be reset to 10.4% per annum on March 31, 2024. This new interest rate is equal to the annual average percentage change in the "All-items Consumer Price Index" published by Statistics Canada during the 12 month period ending on December 31, 2023 plus 6.5% and will be reflected in the June 30, 2024 interest payment on the Debentures.
The current interest rate of 13.3% will remain in place until March 30, 2024. The interest rate applicable to the Debentures will continue to be reset on an annual basis on March 31 of each year.
Further details regarding the Debentures can be found in the final short form prospectus of the Company dated April 17, 2015 which has been filed on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
About Constellation Software Inc.
Constellation Software acquires, manages and builds vertical market software businesses that provide mission-critical software solutions.
Flourish Ventures, an early-stage venture capital firm with purpose, today announced the appointment of Ravi Kaushik as Executive Director, Head of Asia Investments. Ravi will lead the global firm's fintech investments and portfolio management in...
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of information and communication technology solutions, today announced that it was honored with 2023 Climate...
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...
